NCT02767258

Brief Summary

Clinical trial for prevention, randomized controlled, parallel, double-blind, with three arms, which purpose is verify the nursing interventions (artificial tear gel and liquid artificial tears)effects to prevent dry eye in adult patients admitted in ICU.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 10, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

February 14, 2017

Status Verified

February 1, 2017

Enrollment Period

1.7 years

First QC Date

May 6, 2016

Last Update Submit

February 13, 2017

Conditions

Keywords

Dry eyeDiseases of the eye and adnexa

Outcome Measures

Primary Outcomes (1)

  • Dry Eye

    Interventions will be applied in both eyes of the patients from 12 to 12 hours for five consecutive days. Schirmer test will be applyed to evaluate the lacrimal volume. Fluorescein test will be applyed to evaluate the ocular surface.

    Five consecutive days

Study Arms (2)

Sham Comparator: Eye drop

ACTIVE COMPARATOR

Eye drop LACRIBELL® - two drops each eye, two times a day, after eye cleansing.

Device: LACRIBELL®

VIDISIC® GEL

EXPERIMENTAL

Ocular gel VIDISIC® GEL applied two times a day at the lower palpebra from medium line to the lateral border.

Device: VIDISIC® GEL

Interventions

Hypromellose and dextran based eyedrop, used in the treatment of dry eye.

Also known as: liquid artificial tears, eyedrop
Sham Comparator: Eye drop

Carbomer based gel, used in the treatment of dry eye.

Also known as: artificial tear gel
VIDISIC® GEL

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be over 18 years;
  • Did not present dry eye at the time of admission;
  • Stay in the ICU for at least 24 hours;
  • Be in mechanical ventilation therapy;
  • Glance less than 5 per minute;
  • Comatose, sedated or Glasgow less than or equal to 7;
  • Consent to participate in research or have.

You may not qualify if:

  • Have not the responsabille authorization;
  • Patients with severe eye disease or with history of adverse effects after use of any of the interventions proposed and not tolerate the treatment: artificial tear gel, artificial tear liquid and saline 0.9%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Santa de Misericórdia Montes Claros

Montes Claros, Minas Gerais, 39402-218, Brazil

RECRUITING

Related Publications (1)

  • de Araujo DD, Almeida NG, Silva PM, Ribeiro NS, Werli-Alvarenga A, Chianca TC. Prediction of risk and incidence of dry eye in critical patients. Rev Lat Am Enfermagem. 2016;24:e2689. doi: 10.1590/1518-8345.0897.2689. Epub 2016 May 17.

    PMID: 27192415BACKGROUND

MeSH Terms

Conditions

Dry Eye SyndromesEye Diseases

Condition Hierarchy (Ancestors)

Lacrimal Apparatus Diseases

Study Officials

  • Diego D Araújo, PhD student

    State University of Montes Claros, Minas Gerais, Brazil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Diego D Araújo, PhD student

CONTACT

Tânia CM Chianca, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Teacher and Student Doctoral Nursing

Study Record Dates

First Submitted

May 6, 2016

First Posted

May 10, 2016

Study Start

May 1, 2016

Primary Completion

December 31, 2017

Study Completion

December 31, 2019

Last Updated

February 14, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

The study and the information provided will be confidential and used only for purposes of this research. Disclosure of information will be anonymous and in conjunction with the responses of a group of people, never individually.

Locations